Grant: Engage Grants Program
McGill University
$25,000.00
Antimicrobial activity of peptides against plant pathogens and food-borne pathogens
FY 2016-17
Summary
GREENSKY LABS (GSL) is a licensed company operating out of Victoria, BC, whose mission is to bringsuperior science, unique products, and patented technologies to the development of cannabinoid medicines,products, and plant cultivation. The company focuses on plant science and product development as well as onextraction, phytocannabinoid isolation, and custom reformulation technologies.GSL owns several cationic broad-spectrum antimicrobial peptides [AMP] and one of their main goals is toassess the antimicrobial potential of AMP on important Cannabis pathogens using a high throughput screeningmethod and select the best performing AMP for downstream applications- i.e., the over expression oftransgenes encoding AMP in Cannabis leading to enhanced resistance and protection against pathogens.The collaboration with the applicant, who possesses the expertise in molecular plant pathology andmicrobiology, and the specialized research capabilities that are required to assist the company in evaluating theeffectiveness of selective AMP as alternatives to pesticides for the control of fungal and bacterial pathogens ofmedical Cannabis.This project will fund in part the salary of a Research Assistant and covers the costs of microbiological andmolecular biology assays.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
492385-2015
Name nom
Jabaji, Suha
Department département
Plant Science
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
104
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Crop management (pest,disease control and breeding)
Area of application fr
Gestion des cultures (lutte contre les organismes nuisibles et reproduction)
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
1
Nb partie
1
Application title
Antimicrobial activity of peptides against plant pathogens and food-borne pathogens
Keyword
NSERC
Application summary
GREENSKY LABS (GSL) is a licensed company operating out of Victoria, BC, whose mission is to bringsuperior science, unique products, and patented technologies to the development of cannabinoid medicines,products, and plant cultivation. The company focuses on plant science and product development as well as onextraction, phytocannabinoid isolation, and custom reformulation technologies.GSL owns several cationic broad-spectrum antimicrobial peptides [AMP] and one of their main goals is toassess the antimicrobial potential of AMP on important Cannabis pathogens using a high throughput screeningmethod and select the best performing AMP for downstream applications- i.e., the over expression oftransgenes encoding AMP in Cannabis leading to enhanced resistance and protection against pathogens.The collaboration with the applicant, who possesses the expertise in molecular plant pathology andmicrobiology, and the specialized research capabilities that are required to assist the company in evaluating theeffectiveness of selective AMP as alternatives to pesticides for the control of fungal and bacterial pathogens ofmedical Cannabis.This project will fund in part the salary of a Research Assistant and covers the costs of microbiological andmolecular biology assays.